For instance during tumorigenesis of urogenital neoplasms, receptors such as somatostatin, bombesin, cholecystokinin, epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), several types of integrin receptors, or anti-Müllerian hormone receptor type II (AMHR-II), show a higher expression rate on cancer cells than on normal cells. Here, AMHR2 is linked to cancer.